Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-09

FDA Approved: LORAZEPAM — Supplemental Application (International Medication Systems, Limited)

View source ↗

Summary

FDA approves a supplemental application for Lorazepam submitted by International Medication Systems, Limited, enabling its generic formulation to be marketed in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)